Martina Minnerop

Summary

Country: Germany

Publications

  1. ncbi The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease
    Martina Minnerop
    Department of Neurology, University Hospital of Bonn, 53105 Bonn, Germany
    Brain 134:3530-46. 2011
  2. ncbi Callosal tissue loss in multiple system atrophy--a one-year follow-up study
    Martina Minnerop
    Institute of Neurosciences and Medicine 1, Research Centre Julich, Julich, Germany
    Mov Disord 25:2613-20. 2010
  3. ncbi Exon deletions and intragenic insertions are not rare in ataxia with oculomotor apraxia 2
    Veronica Bernard
    Institut fur Humangenetik, Universitat zu Lubeck, Lubeck, Germany
    BMC Med Genet 10:87. 2009
  4. ncbi Grey and white matter loss along cerebral midline structures in myotonic dystrophy type 2
    Martina Minnerop
    Department of Neurology, University Hospital of Bonn, Sigmund Freud Strasse 25, Bonn, Germany
    J Neurol 255:1904-9. 2008
  5. ncbi In vitro evaluation of nicotinic acetylcholine receptors with 2-[18F]F-A85380 in Parkinson's disease
    Jorn Schmaljohann
    Department of Neurology, University of Bonn, Germany
    Nucl Med Biol 33:305-9. 2006
  6. ncbi Smoking upregulates alpha4beta2* nicotinic acetylcholine receptors in the human brain
    Ullrich Wullner
    Department of Neurology, University Bonn, Sigmund Freud Strasse 25, 53105 Bonn, Germany
    Neurosci Lett 430:34-7. 2008
  7. ncbi In vivo voxel-based relaxometry in amyotrophic lateral sclerosis
    Martina Minnerop
    Dept of Neurology, University Hospital of Bonn, Sigmund Freud Str 25, 53105 Bonn, Germany
    J Neurol 256:28-34. 2009
  8. ncbi Feasibility of 2-deoxy-2-[18F]fluoro-D-glucose- A85380-PET for imaging of human cardiac nicotinic acetylcholine receptors in vivo
    Jan Bucerius
    University of Bonn, Department of Nuclear Medicine, Sigmund Freud Str 25, 53105 Bonn, Germany
    Clin Res Cardiol 95:105-9. 2006
  9. ncbi Stochastic resonance therapy in Parkinson's disease
    Oliver Kaut
    Department of Neurology, University of Bonn, Bonn, Germany
    NeuroRehabilitation 28:353-8. 2011
  10. ncbi Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6
    Ullrich Wullner
    Department of Neurology, University of Bonn, Bonn, Germany
    Arch Neurol 62:1280-5. 2005

Collaborators

Detail Information

Publications13

  1. ncbi The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease
    Martina Minnerop
    Department of Neurology, University Hospital of Bonn, 53105 Bonn, Germany
    Brain 134:3530-46. 2011
    ..White matter changes dominated the extent of grey matter changes, which might argue against Wallerian degeneration as the major cause of white matter affection in myotonic dystrophies...
  2. ncbi Callosal tissue loss in multiple system atrophy--a one-year follow-up study
    Martina Minnerop
    Institute of Neurosciences and Medicine 1, Research Centre Julich, Julich, Germany
    Mov Disord 25:2613-20. 2010
    ..Callosal atrophy may possibly reflect a disease-specific pattern of neurodegeneration and cortical atrophy, fitting well with the predominant impairment of motor functions in the MSA patients...
  3. ncbi Exon deletions and intragenic insertions are not rare in ataxia with oculomotor apraxia 2
    Veronica Bernard
    Institut fur Humangenetik, Universitat zu Lubeck, Lubeck, Germany
    BMC Med Genet 10:87. 2009
    ..AOA2 is caused by mutations within the senataxin gene (SETX). The majority of known mutations are nonsense, missense, and splice site mutations, as well as small deletions and insertions...
  4. ncbi Grey and white matter loss along cerebral midline structures in myotonic dystrophy type 2
    Martina Minnerop
    Department of Neurology, University Hospital of Bonn, Sigmund Freud Strasse 25, Bonn, Germany
    J Neurol 255:1904-9. 2008
    ..The reduced size of the corpus callosum further extends the spectrum of white matter changes in DM2 and may represent the morphological substrate of neuropsychological abnormalities previously described in this disorder...
  5. ncbi In vitro evaluation of nicotinic acetylcholine receptors with 2-[18F]F-A85380 in Parkinson's disease
    Jorn Schmaljohann
    Department of Neurology, University of Bonn, Germany
    Nucl Med Biol 33:305-9. 2006
    ..The observed pattern of alpha4beta2* nAChR loss demonstrates the potential of 2-[18F]F-A85380 for further investigations of this positron emission tomography ligand for in vivo studies of alpha4beta2* nAChRs in PD...
  6. ncbi Smoking upregulates alpha4beta2* nicotinic acetylcholine receptors in the human brain
    Ullrich Wullner
    Department of Neurology, University Bonn, Sigmund Freud Strasse 25, 53105 Bonn, Germany
    Neurosci Lett 430:34-7. 2008
    ..The up-regulation of alpha4beta2* nAChR upon chronic nicotine exposure via tobacco smoking incorporates subcortical brain regions which may play an important role in nicotine addiction...
  7. ncbi In vivo voxel-based relaxometry in amyotrophic lateral sclerosis
    Martina Minnerop
    Dept of Neurology, University Hospital of Bonn, Sigmund Freud Str 25, 53105 Bonn, Germany
    J Neurol 256:28-34. 2009
    ..Larger prospective studies are necessary to evaluate the usefulness and relevance of VBR and ROI-based analysis of R2 maps in clinical practice...
  8. ncbi Feasibility of 2-deoxy-2-[18F]fluoro-D-glucose- A85380-PET for imaging of human cardiac nicotinic acetylcholine receptors in vivo
    Jan Bucerius
    University of Bonn, Department of Nuclear Medicine, Sigmund Freud Str 25, 53105 Bonn, Germany
    Clin Res Cardiol 95:105-9. 2006
    ..These first results suggest no impact of either PD or MSA on cardiac nicotinic acetylcholine receptors...
  9. ncbi Stochastic resonance therapy in Parkinson's disease
    Oliver Kaut
    Department of Neurology, University of Bonn, Bonn, Germany
    NeuroRehabilitation 28:353-8. 2011
    ..To test the effects of stochastic whole body vibration (WBV) we performed a double-blind randomized controlled study...
  10. ncbi Dopamine transporter positron emission tomography in spinocerebellar ataxias type 1, 2, 3, and 6
    Ullrich Wullner
    Department of Neurology, University of Bonn, Bonn, Germany
    Arch Neurol 62:1280-5. 2005
    ....
  11. ncbi Bell's palsy: combined treatment of famciclovir and prednisone is superior to prednisone alone
    Martina Minnerop
    Dept of Neurology, University Hospital of Bonn, Sigmund Freud Str 25, 53105 Bonn, Germany
    J Neurol 255:1726-30. 2008
    ..7 % vs. 47.1 %; Cochran-Armitage trend test, p = 0.03). These results suggest that the combined treatment of famciclovir and prednisolone should be considered (at least) in patients with severe BP...
  12. ncbi The time course of neurolinguistic and neuropsychological symptoms in three cases of logopenic primary progressive aphasia
    Louise Etcheverry
    Research Centre Julich, Institute for Neuroscience and Medicine INM 1, INM 2, Julich, Germany
    Neuropsychologia 50:1708-18. 2012
    ..These deficits may further interact and thus form a multi-causal basis for the patients' problems in every-day life which need to be considered when planning individually targeted intervention in PPA...
  13. ncbi REM sleep behavioral disorder in pure autonomic failure (PAF)
    Anja Weyer
    Department of Neurology, University Hospital Bonn, Germany
    Neurology 66:608-9. 2006